Bremelanotide: A Melanocortin Receptor Agonist for the Treatment of FSD

Key finding

Method / model

Relevance

Rosen, R.C. et al. (2015). Bremelanotide: A Melanocortin Receptor Agonist for the Treatment of FSD. Expert Opinion on Pharmacotherapy.